XXII

22nd Century Group Inc. (XXII) | Rumor.io

22nd Century Group

XXII

Attention (50-day avg)0%

Attention rank (50-day avg)#1,223

Bullish sentiment (50-day avg)50%

Price to earnings ratio0

Market capitalization681.9K

Earnings per share2.3K

Dividend yield (TTM)—

Revenue (annual)7M

Net income (annual)-5.1M

Social

What share of all stock conversation is about XXII?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% +0	0% 0	0% -0.01

Sep 28

22nd Century Group's reduced-nicotine tobacco platform is ready to supply France's nicotine-reduction initiative, potentially supporting the company's share price.
The management of 22nd Century Group has been criticized for making more in salaries than the company's worth, and the company's market capitalization has declined significantly.
The company's history of supporting nicotine-reduction initiatives in various countries, including New Zealand, Australia, Canada, South Korea, Japan, and Switzerland, has been cited as a reason for skepticism about the France initiative's impact on the company's share price.

Generated by AI

Sentiment

Of the messages about XXII that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	0% 0	32% -1.33	35.4% -23.1	57.68% -1.88
Bearish	100% 0	68% +1.33	64.6% +23.1	42.32% +1.88

Bullish· Aug 13

The company has a strong intellectual property portfolio, which enhances its competitive advantage and safeguards its technology.
22nd Century Group has established itself as a pioneer in the tobacco harm reduction movement, advocating for less harmful alternatives to traditional smoking.
The company's VLN cigarettes are the only commercially available combustible low nicotine products authorized by the FDA in the United States, underscoring the scientific backing and regulatory acceptance of their innovative products.

Bearish· Jun 12

The company's stock price would be around 15 cents if not for reverse stock splits, according to a post.
The company has a history of issuing stock after reverse splits, which is the reason it stays afloat, according to a post.
The stock will get shorted and warrant exercised back to below $1.00 by the end of the year, according to a post.

Generated by AI

Topics

Of the messages about XXII that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	—	25.26%	39.92%	46.87%
Macro	—	36.6%	29.22%	15.52%
Controversies	—	2.58%	2.47%	3.13%
Analysts	—	35.05%	27.98%	12.84%
Technical Analysis	—	0.52%	0.41%	20.95%
Earnings	—	0%	0%	0.69%

Earnings· Aug 7

$XXII Reports Q2 EPS loss of $0.05 and revenue of $6.92M (+77.4% Y/Y).
The company's Q2 results show a significant revenue increase, but also a substantial operating loss.
The post suggests that the Q2 earnings report had both bullish and bearish implications for investors.

Announcements· Sep 25

22nd Century Group, Inc. (XXII) secured $9.5 million in cash proceeds from an insurance claim settlement, clearing all senior debt and achieving a debt-free status.
The company plans to shift from survival capital to growth capital, aiming to drive profitability in 2026, with expanding VLN product distribution and sales momentum building.
With a very low float of approximately 3.5 million shares and a strong stock price performance, XXII is considered a potential target for growth, with some analysts predicting a price range of $3-$3.5.

Controversies· Apr 28

The FDA is likely to publish proposed rules to ban menthol cigarettes, which could lead to years of litigation from Big Tobacco.
Some Black health leaders and civil rights organizations support prohibiting menthol cigarettes, but others warn that a ban would turn Black smokers into lawbreakers and lead to confrontations with police.
The FDA's proposed ban on menthol cigarettes would target distributors, stores, and retailers, not individuals, according to the FDA's order.

Technical Analysis· Sep 25

$XXII is forming a pennant and at a key price level, waiting to see if there's momentum for a breakout.
$XXII has broken a downtrend and is watching for a breakout over $2.07 to confirm continuation, with momentum holding as long as VWAP acts as support.
$XXII is testing $1.50 support, a hold could mean a bounce to $1.85, but a break risks further downside.

Generated by AI

Community

Of the messages about XXII, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	100%	53.16%	57.27%	64.27%
Newcomers	0%	46.84%	42.73%	35.73%

Regulars· Sep 28

The regulars are concerned about the lack of trust in 22nd Century Group, Inc. (XXII) and its potential impact on the company's future, with some expressing hope and others skepticism.
The company's management has been criticized for its compensation and the perceived lack of value in the company, with some regulars joking about the situation.
There are concerns about the company's ability to increase its dividend without causing addiction, and some are worried about the potential for dilution, with one regular speculating about the company's business plan.

Newcomers· Aug 27

22nd Century Group, a tobacco company, has developed VLN technology, which reduces nicotine in cigarettes by 95%.
The company is expanding its retail distribution across the US and has a strong financial position, with $6.1 million in cash and no outstanding debt.
22nd Century Group's marketing strategy focuses on brand-building, consumer engagement, and trial increase, with a goal of turning first-time buyers into loyal customers.

Generated by AI

Independent French health agency ANSES recommends a maximum nicotine limit for all combustible tobacco product; the Company's supply now includes non-GMO reduced-nicotine tobacco, addressing a key feasibility question for France and the EU MOCKSVILLE, N.C., Sept. 28, 2026 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), the only low nicotine tobacco company in the world, today highlighted the findings of a scientific assessment published by ANSES, France's National Agency for Food, E

1d agoYahoo Finance

Full Transcript: 22nd Century Group Q2 2026 Earnings Call - 22nd Century Gr (NASDAQ:XXII)

22nd Century Group (NASDAQ:XXII) released second-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. Benzinga APIs provide real-time access to earnings call transcripts

8d agoBenzinga

22nd Century CEO & Chairman Larry Firestone: Improved Gross Margin, ~5,000 Retail Outlets and >$50B Market Opportunity Highlight Mid-Year Stockholder Letter

VLN® Category Leader Accelerates 2H 2026 Growth Phase as Same-Store Sales Climb 22nd Century Accelerates 2H 2026 Commercial Execution MOCKSVILLE, N.C., Sept. 01, 2026 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), the leader in low-nicotine tobacco, low-nicotine cigarettes and the only tobacco products company focused on reducing the harms of smoking through nicotine reduction, today issued the following letter to stockholders from Lawrence Firestone, the Chief Executive Officer of

28d agoYahoo Finance

22nd Century Group to Participate in the HC Wainwright Conference on September 15, 2026

MOCKSVILLE, N.C., Aug. 18, 2026 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), the only tobacco products company that has for 28 years led and continues to lead the fight against the harms of smoking driven by nicotine addiction, today announced that it will participate in the HC Wainwright Conference on September 15, 2026 at the Lotte New York Palace Hotel. Investors can register and request meetings with management via their HC Wainwright representative. Attending the conference

1mo agoYahoo Finance

22nd Century Group Inc (XXII) (Q2 2026) Earnings Call Highlights: Strategic Shift Toward ...

Company expands Pinnacle VLN distribution to nearly 150 stores in Metro New York while navigating transition away from low-margin contract manufacturing.

1mo agoYahoo Finance

Earnings call transcript: 22nd Century Group posts steep Q2 2026 miss

1mo agoInvesting.com

Also Discussed

Investors talking about XXII also mention

#	Name	Attention
1	IGC Pharma Inc.IGC	0.01%+0
2	Delcath Systems, Inc.DCTH	0%new
3	My Size, Inc.MYSZ	0%new
4	ZYNE - Zynerba Pharmaceuticals, Inc.	——
5	CARA - Cara Therapeutics, Inc.	——
6	Turning Point Brands, Inc.TPB	0%new
7	British American Tobacco plc ADRBTI	0.01%+0.01
8	Xtant Medical Holdings Inc.XTNT	0%0
9	Cronos Group Inc.CRON	0%0
10	Palatin Technologies, Inc.PTN	0%0

22nd Century Group Inc.

Consumer Defensive
Tobacco

22nd Century Group Inc. is a biotechnology company specializing in the genetic engineering of tobacco and cannabis plants. The company's primary function is to develop plant varieties with modified levels of nicotine and cannabinoid profiles, aiming to meet evolving consumer and regulatory demands. A key feature of 22nd Century Group Inc. is its focus on creating low-nicotine tobacco products and hemp/cannabis plants with specific cannabinoid contents. These innovations have significant implications for the agricultural biotechnology sector and public health policy discussions regarding tobacco harm reduction. By leveraging its proprietary genetic technologies and collaborations, the company positions itself as a leader in altering plant alkaloid content to enhance product offerings and create potentially safer tobacco alternatives. Headquartered in the United States, 22nd Century Group Inc. plays a strategic role in both the tobacco and cannabis industries, addressing the growing need for reduced-risk products while exploring the vast potential of cannabinoid applications. Its contributions reflect broader trends in biotechnology, agriculture, and consumer health advocacy, making it a company of interest in these intersecting fields.

Website

Location

321 Farmington Road

Mocksville, NC, 27028

United States

Social

What share of all stock conversation is about XXII?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% +0	0% 0	0% -0.01

Sep 28

22nd Century Group's reduced-nicotine tobacco platform is ready to supply France's nicotine-reduction initiative, potentially supporting the company's share price.
The management of 22nd Century Group has been criticized for making more in salaries than the company's worth, and the company's market capitalization has declined significantly.
The company's history of supporting nicotine-reduction initiatives in various countries, including New Zealand, Australia, Canada, South Korea, Japan, and Switzerland, has been cited as a reason for skepticism about the France initiative's impact on the company's share price.

Generated by AI

Sentiment

Of the messages about XXII that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	0% 0	32% -1.33	35.4% -23.1	57.68% -1.88
Bearish	100% 0	68% +1.33	64.6% +23.1	42.32% +1.88

Bullish· Aug 13

The company has a strong intellectual property portfolio, which enhances its competitive advantage and safeguards its technology.
22nd Century Group has established itself as a pioneer in the tobacco harm reduction movement, advocating for less harmful alternatives to traditional smoking.
The company's VLN cigarettes are the only commercially available combustible low nicotine products authorized by the FDA in the United States, underscoring the scientific backing and regulatory acceptance of their innovative products.

Bearish· Jun 12

The company's stock price would be around 15 cents if not for reverse stock splits, according to a post.
The company has a history of issuing stock after reverse splits, which is the reason it stays afloat, according to a post.
The stock will get shorted and warrant exercised back to below $1.00 by the end of the year, according to a post.

Generated by AI

Topics

Of the messages about XXII that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	—	25.26%	39.92%	46.87%
Macro	—	36.6%	29.22%	15.52%
Controversies	—	2.58%	2.47%	3.13%
Analysts	—	35.05%	27.98%	12.84%
Technical Analysis	—	0.52%	0.41%	20.95%
Earnings	—	0%	0%	0.69%

Earnings· Aug 7

$XXII Reports Q2 EPS loss of $0.05 and revenue of $6.92M (+77.4% Y/Y).
The company's Q2 results show a significant revenue increase, but also a substantial operating loss.
The post suggests that the Q2 earnings report had both bullish and bearish implications for investors.

Announcements· Sep 25

22nd Century Group, Inc. (XXII) secured $9.5 million in cash proceeds from an insurance claim settlement, clearing all senior debt and achieving a debt-free status.
The company plans to shift from survival capital to growth capital, aiming to drive profitability in 2026, with expanding VLN product distribution and sales momentum building.
With a very low float of approximately 3.5 million shares and a strong stock price performance, XXII is considered a potential target for growth, with some analysts predicting a price range of $3-$3.5.

Controversies· Apr 28

The FDA is likely to publish proposed rules to ban menthol cigarettes, which could lead to years of litigation from Big Tobacco.
Some Black health leaders and civil rights organizations support prohibiting menthol cigarettes, but others warn that a ban would turn Black smokers into lawbreakers and lead to confrontations with police.
The FDA's proposed ban on menthol cigarettes would target distributors, stores, and retailers, not individuals, according to the FDA's order.

Technical Analysis· Sep 25

$XXII is forming a pennant and at a key price level, waiting to see if there's momentum for a breakout.
$XXII has broken a downtrend and is watching for a breakout over $2.07 to confirm continuation, with momentum holding as long as VWAP acts as support.
$XXII is testing $1.50 support, a hold could mean a bounce to $1.85, but a break risks further downside.

Generated by AI

Community

Of the messages about XXII, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	100%	53.16%	57.27%	64.27%
Newcomers	0%	46.84%	42.73%	35.73%

Regulars· Sep 28

The regulars are concerned about the lack of trust in 22nd Century Group, Inc. (XXII) and its potential impact on the company's future, with some expressing hope and others skepticism.
The company's management has been criticized for its compensation and the perceived lack of value in the company, with some regulars joking about the situation.
There are concerns about the company's ability to increase its dividend without causing addiction, and some are worried about the potential for dilution, with one regular speculating about the company's business plan.

Newcomers· Aug 27

22nd Century Group, a tobacco company, has developed VLN technology, which reduces nicotine in cigarettes by 95%.
The company is expanding its retail distribution across the US and has a strong financial position, with $6.1 million in cash and no outstanding debt.
22nd Century Group's marketing strategy focuses on brand-building, consumer engagement, and trial increase, with a goal of turning first-time buyers into loyal customers.

Generated by AI

22nd Century Group

Social

Sep 28

Bullish· Aug 13

Bearish· Jun 12

Earnings· Aug 7

Announcements· Sep 25

Controversies· Apr 28

Technical Analysis· Sep 25

Regulars· Sep 28

Newcomers· Aug 27

22nd Century Group's Reduced-Nicotine Tobacco Platform Positioned to Support France's Nicotine-Reduction Initiative

Full Transcript: 22nd Century Group Q2 2026 Earnings Call - 22nd Century Gr (NASDAQ:XXII)

22nd Century CEO & Chairman Larry Firestone: Improved Gross Margin, ~5,000 Retail Outlets and >$50B Market Opportunity Highlight Mid-Year Stockholder Letter

22nd Century Group to Participate in the HC Wainwright Conference on September 15, 2026

22nd Century Group Inc (XXII) (Q2 2026) Earnings Call Highlights: Strategic Shift Toward ...

Earnings call transcript: 22nd Century Group posts steep Q2 2026 miss

Also Discussed

22nd Century Group Inc.

Company Information

Location

22nd Century Group's Reduced-Nicotine Tobacco Platform Positioned to Support France's Nicotine-Reduction Initiative

Full Transcript: 22nd Century Group Q2 2026 Earnings Call - 22nd Century Gr (NASDAQ:XXII)

22nd Century CEO & Chairman Larry Firestone: Improved Gross Margin, ~5,000 Retail Outlets and >$50B Market Opportunity Highlight Mid-Year Stockholder Letter

22nd Century Group to Participate in the HC Wainwright Conference on September 15, 2026

22nd Century Group Inc (XXII) (Q2 2026) Earnings Call Highlights: Strategic Shift Toward ...

Earnings call transcript: 22nd Century Group posts steep Q2 2026 miss

Also Discussed

Social

Sep 28

Bullish· Aug 13

Bearish· Jun 12

Earnings· Aug 7

Announcements· Sep 25

Controversies· Apr 28

Technical Analysis· Sep 25

Regulars· Sep 28

Newcomers· Aug 27